Search clinical trials for: Dose decrease

Total 7779 results

Themis Bioscience GmbH

Completed

Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)

Chikungunya Virus Infection

United Kingdom
Al-Azhar University
Benha University

Not yet recruiting

Comparative Dose-Response of Intrathecal Dexmedetomidine for Post-Spinal Shivering

Post-Spinal Shivering

Egypt
Union Hospital, Tongji Medical College, Huazhong...
Yichang Humanwell Pharmaceutical Co., Ltd., China

Completed

Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

Mechanically Ventilated Patients

China
Shanghai Zerun Biotechnology Co.,Ltd
Walvax Biotechnology Co., Ltd.

Active, not recruiting

Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

COVID-19

China
Boehringer Ingelheim

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

Hepatitis C, Chronic
Pfizer

Completed

Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine

Influenza

United States
Nuritas Ltd

Completed

A Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals

Overweight | Pre Diabetes

India
IntegoGen, LLC

Withdrawn

Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression

Bipolar Depression

Poland
Daewoong Bio Inc.

Completed

Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects

Dry Eye Syndromes

Korea, Republic of
NIZO Food Research
FrieslandCampina

Completed

The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection (MIRRE)

Diarrhea

Netherlands
Leiden University Medical Center

Completed

Perfect Fit: Evaluation of a Virtual Coach for Smoking Cessation and Physical Activity

Smoking | Low Physical Activity Level

Netherlands
Bausch & Lomb Incorporated

Not yet recruiting

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

Pain, Postoperative
Emory University
National Institute on Drug Abuse (NIDA)

Recruiting

Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches

Nicotine Addiction

United States
Shenzhen Wingor Biotechnology Co., Ltd.
Beijing Tiantan Hospital

Recruiting

A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS

Acute Ischemic Stroke AIS

China
ADARx Pharmaceuticals, Inc.

Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

IgAN | C3G | IC-MPGN | IgA Nephropathy (IgAN) | Complement-mediated Kidney Disease

United States, Australia, Hong Kong, South Korea, Spain, United Kingdom
Fundacion para la Investigacion Biomedica del Hospital...

Not yet recruiting

Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses

Actinic Keratoses
Anhui Provincial Hospital

Recruiting

Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Toxicity Due to Radiotherapy

China
Olfred Hansen
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaborators

Recruiting

Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®

NSCLC

Denmark
NexThera Co., Ltd.
KCRN Research, LLC

Completed

NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

Wet AMD | Wet Age Related Macular Degeneration

United States
Jiangsu Province Centers for Disease Control and...

Completed

PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Streptococcus Pneumoniae Pneumonia

China
EncuraGen, Inc

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (PEG)-BHD1028

Insulin Resistance

United States
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
Yale University
Agency for Healthcare Research and Quality (AHRQ)

Completed

Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone

Kidney Stones

United States
University of Pennsylvania

Completed

Ghrelin Dose Finding In Frail Elderly

The Frailty Syndrome

United States
Janssen Research & Development, LLC

Terminated

A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies

Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Leukemia, Lymphocytic, Chronic, B-Cell

United States, France, Spain, Belgium, Israel
LanZhou University

Completed

The Organ Protection of Astragalus in Subjects With Metabolic Syndrome

Metabolic Syndrome

China
Juventas Therapeutics, Inc.

Unknown

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. (STOP-HF)

Ischemic Heart Failure

United States
Boehringer Ingelheim

Completed

Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions

Healthy

Germany
Zhejiang University

Completed

The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia

Hyperlipoproteinemia
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
Hvivo

Completed

Dose, Safety and Pathogenicity of SARS-CoV-2 (COVID-19) Omicron Virus (BA.5)

SARS-CoV-2 Infection

United Kingdom
AC Immune SA
ICON Clinical Research

Active, not recruiting

A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease (VacSYn)

Parkinson Disease | Parkinson Disease 6, Early-Onset

Spain, United Kingdom, Germany
Boehringer Ingelheim

Completed

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Hepatitis C, Chronic

France, Germany, Switzerland
Cellular Biomedicine Group Ltd.
RenJi Hospital

Completed

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis

Knee Osteoarthritis

China
Pearl Therapeutics, Inc.

Completed

Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers

Healthy Volunteers

United States
Merck Sharp & Dohme LLC

Completed

Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)

Melanoma

Australia, South Africa, Spain, Sweden
Vanderbilt University Medical Center

Withdrawn

How Does Platelet Dose Impact Clinical Outcomes After PRP Treatment?

Osteoarthritis, Knee

United States
Pfizer

Completed

A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

Hypercholesterolemia

United States
Wayne State University
National Institute of Mental Health (NIMH)

Recruiting

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder (CALM)

Anxiety Disorders | Generalized Anxiety Disorder (GAD)

United States
Vaxcyte, Inc.

Completed

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

Pneumococcal Vaccines

United States
ProDa BioTech, LLC
National Cancer Institute (NCI)

Completed

ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Advanced Pancreatic Cancer | Solid Tumor Malignancies

United States
Beacon Therapeutics

Enrolling by invitation

A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)

X-Linked Retinitis Pigmentosa

United States
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression

Major Depressive Disorder

Poland
First Affiliated Hospital Xi'an Jiaotong University
Eureka Therapeutics Inc.

Unknown

ET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and Lymphoma

CD19+ Lymphoma, B-Cell | CD19+ Leukemia, B-Cell

China
Fangbiao Tao

Not yet recruiting

Study of the Intervention Effect of Outdoor Activity Period Patterns in Promoting Myopia Among Preschool Children

Myopia | Axial Length
Universidad Miguel Hernandez de Elche

Not yet recruiting

Improving Therapeutic Adherence in Cardiovascular Secondary Prevention. (AT-PSC)

Cardiovascular Diseases | Coronary Disease | Chronic Disease | Secondary Prevention

Spain
NYU Langone Health

Recruiting

Telephone-Based Support Programs for People With Epilepsy

Epilepsy

United States
Siriraj Hospital

Recruiting

Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer (PostOP HYPOCxE)

Cervix Cancer | Endometrial Cancer

Thailand
Zhujiang Hospital

Recruiting

Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)

Continuous Renal Replacement Therapy (CRRT)

China

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations